Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $8.18 million. The enterprise value is $178.04 million.
| Market Cap | 8.18M |
| Enterprise Value | 178.04M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 6.10 million shares outstanding. The number of shares has increased by 8.01% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +8.01% |
| Shares Change (QoQ) | +2.48% |
| Owned by Insiders (%) | 4.10% |
| Owned by Institutions (%) | 19.31% |
| Float | 5.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| Forward PS | 0.05 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82
| Current Ratio | 1.82 |
| Quick Ratio | 1.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.15% |
| Return on Invested Capital (ROIC) | -10.80% |
| Return on Capital Employed (ROCE) | -19.38% |
| Weighted Average Cost of Capital (WACC) | 4.41% |
| Revenue Per Employee | $785,348 |
| Profits Per Employee | -$163,183 |
| Employee Count | 224 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.07% in the last 52 weeks. The beta is 0.79, so Cardlytics's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -91.07% |
| 50-Day Moving Average | 2.59 |
| 200-Day Moving Average | 5.71 |
| Relative Strength Index (RSI) | 28.12 |
| Average Volume (20 Days) | 75,177 |
Short Selling Information
The latest short interest is 475,225, so 7.79% of the outstanding shares have been sold short.
| Short Interest | 475,225 |
| Short Previous Month | 498,325 |
| Short % of Shares Out | 7.79% |
| Short % of Float | 8.83% |
| Short Ratio (days to cover) | 5.52 |
Income Statement
In the last 12 months, Cardlytics had revenue of $175.92 million and -$36.55 million in losses. Loss per share was -$6.47.
| Revenue | 175.92M |
| Gross Profit | 87.43M |
| Operating Income | -34.00M |
| Pretax Income | -46.72M |
| Net Income | -36.55M |
| EBITDA | -9.61M |
| EBIT | -34.00M |
| Loss Per Share | -$6.47 |
Balance Sheet
The company has $29.95 million in cash and $199.81 million in debt, with a net cash position of -$169.86 million or -$27.84 per share.
| Cash & Cash Equivalents | 29.95M |
| Total Debt | 199.81M |
| Net Cash | -169.86M |
| Net Cash Per Share | -$27.84 |
| Equity (Book Value) | -23.02M |
| Book Value Per Share | -3.89 |
| Working Capital | 43.44M |
Cash Flow
In the last 12 months, operating cash flow was -$7.13 million and capital expenditures -$75,000, giving a free cash flow of -$7.20 million.
| Operating Cash Flow | -7.13M |
| Capital Expenditures | -75,000 |
| Depreciation & Amortization | 24.39M |
| Net Borrowing | -21.07M |
| Free Cash Flow | -7.20M |
| FCF Per Share | -$1.18 |
Margins
Gross margin is 49.70%, with operating and profit margins of -19.33% and -20.78%.
| Gross Margin | 49.70% |
| Operating Margin | -19.33% |
| Pretax Margin | -26.56% |
| Profit Margin | -20.78% |
| EBITDA Margin | -5.46% |
| EBIT Margin | -19.33% |
| FCF Margin | n/a |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.01% |
| Shareholder Yield | -8.01% |
| Earnings Yield | -483.03% |
| FCF Yield | -88.10% |
Analyst Forecast
The average price target for Cardlytics is $4.43, which is 230.22% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.43 |
| Price Target Difference | 230.22% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 87.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 8, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 8, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Cardlytics has an Altman Z-Score of -8.15 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.15 |
| Piotroski F-Score | 3 |